Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
12.06
-0.16 (-1.31%)
Jul 22, 2026, 10:07 AM EDT - Market open
Evommune Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Evommune stock has a consensus rating of "Buy" and an average price target of $31.14. The average 1-year stock price forecast is 158.21% higher than the current stock price, while the lowest is $22 (+82.42%) and the highest is $54 (+347.76%).
Price Target: $31.14 (+158.21%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Evommune stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 8 | 8 | 5 | 5 |
| Buy | 1 | 2 | 2 | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Clear Street | Clear Street | Buy Maintains $28 | Buy | Maintains | $28 | +132.17% | Jul 16, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $54 | Buy | Maintains | $54 | +347.76% | Jul 6, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $55 → $26 | Buy | Maintains | $55 → $26 | +115.59% | Jun 30, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jun 30, 2026 |
| William Blair | William Blair | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jun 29, 2026 |
Financial Forecast
Revenue This Year
4.13M
from 13.00M
Decreased by -68.27%
Revenue Next Year
1.25M
from 4.13M
Decreased by -69.70%
EPS This Year
-2.79
from -11.22
EPS Next Year
-3.24
from -2.79
EPS and Forward PE are based on non-GAAP adjusted numbers.